Coronary Microvascular Disease: X Marks the Spot

OCTOBER 27, 2023
Ruchi Kapoor, MD, PhD
GRAND ROUND OBJECTIVES
Upon completion of this program, attendees should be able to:
Listeners will understand the limitations of currently available cardiovascular risk assessment and precision medicine tools.
Participants will understand the strengths and limitations of currently available biomarkers, including c-reactive protein, troponins and natriuretic peptides, for risk assessment and therapeutic guidance in cardiovascular prevention. Be familiar with current state of literature
The listener will be able to use actuarial risk assessment for specific cardiovascular outcomes to help guide decisions for CVD prevention and treatment.